Clinicopathological characteristics and survival in lung signet ring cell carcinoma: a population-based study
Open Access
- 15 February 2021
- journal article
- research article
- Published by Association of Basic Medical Sciences of FBIH in Bosnian Journal of Basic Medical Sciences
- Vol. 21 (6), 751-758
- https://doi.org/10.17305/bjbms.2020.5454
Abstract
Lung signet ring cell carcinoma (LSRCC) is a very rare type of lung cancer, the clinical characteristics, and prognosis of which remain to be clarified. In order to explore the clinicopathological and survival-related factors associated with LSRCC, we performed a large population-based cohort analysis of data included in the Surveillance, Epidemiology, and End Results (SEER) registry from 2001- 2015. A total of 752 LSRCC and 7518 lung mucinous adenocarcinoma (LMAC) patients were incorporated into our analysis, with respective mean ages of 63.8 and 67.5 years at the time of diagnosis. LSRCC patients were significantly more likely than LMAC patients to have distant-stage disease (72.1% vs. 45.8%, ppp=0.03), and be < 40 years old (3.3% vs. 1.3%, p=0.022), whereas they were less likely to have undergone surgical treatment (52.4% vs. 77.0%, pp<0.0001), respectively, although these differences were not significant after adjusting for confounding variables. Independent factors associated with a favorable patient prognosis included a primary site in the middle or lower lung lobe, underwent surgery and underwent chemotherapy. However, age ≥ 80 years, higher grade, distant summary stage disease, and T4 stage disease were linked to poor prognosis. Patient age, tumor grade, primary tumor site, summary stage, T stage, surgery, and chemotherapy were all significantly associated with LSRCC patient prognosis.Keywords
This publication has 26 references indexed in Scilit:
- Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung CancerJournal of Thoracic Oncology, 2015
- Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood MarkersJournal of Thoracic Oncology, 2015
- Development and Validation of a Nomogram for Predicting Survival in Patients With Resected Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2015
- Pathological Vascular Invasion and Tumor Differentiation Predict Cancer Recurrence in Stage ia Non–Small-Cell Lung Cancer After Complete Surgical ResectionJournal of Thoracic Oncology, 2012
- E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinomaLaboratory Investigation, 2011
- Primary Signet Ring Cell Carcinoma of the ProstateMayo Clinic Proceedings, 2010
- Signet‐ring cell carcinoma component in primary lung adenocarcinoma: potential prognostic factorHistopathology, 2008
- Primary Lung Carcinoma With Signet-ring Cell Carcinoma ComponentsThe American Journal of Surgical Pathology, 2004
- Detection of the Epstein-Barr virus in primary adenocarcinoma of the lung with Signet-Ring cellsVirchows Archiv A Pathological Anatomy and Histopathology, 2002
- Primary mucinous adenocarcinoma of the lung with signet-ring cells: A histochemical comparison with signet-ring cell carcinomas of other sitesHuman Pathology, 1989